TheodoreErichSpiroMD

Anatomic Pathology, Clinical Pathology

Physician

Dr. Spiro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
11 Benjamin Trl
Pennington, NJ 08534
Phone+1 609-737-5118

Fax+1 609-737-8503

Western Michigan University Homer Stryker MD School of MedicineResidency, Internal Medicine, 1986 - 1988
National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 1980 - 1980
National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 1976 - 1977
NYU Grossman School of MedicineResidency, Pathology-Anatomic and Clinical, 1974 - 1976
NYU Grossman School of MedicineInternship, Internal Medicine, 1973 - 1974
University of Cincinnati College of MedicineClass of 1973

PubMed

195 citations
Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls
Meyer Michel Samama, Genevieve Contant, Theodore E. Spiro, Elisabeth Perzborn, Céline Guinet
Thrombosis and Haemostasis. 2011-12-21
116 citations
Laboratory assessment of rivaroxaban: a review
Meyer Michel Samama, Genevieve Contant, Theodore E. Spiro, Elisabeth Perzborn, Léna Le Flem
Thrombosis Journal. 2013-07-03
125 citations
Assays for measuring rivaroxaban: their suitability and limitations.
Edelgard Lindhoff-Last, Meyer Michel Samama, Thomas L. Ortel, Jeffrey I. Weitz, Theodore E. Spiro
Therapeutic Drug Monitoring. 2010-12-01

Abstracts/Posters

Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies
Theodore E. Spiro, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial
Theodore E. Spiro, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial
Theodore E. Spiro, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Increased Risk of Death in Acutely Ill Medical Patients with Asymptomatic Proximal Deep Vein Thrombosis or Symptomatic Venous Thromboembolism: Insights from the Magell...
Theodore E. Spiro, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Join now to see all